The first Myriad Genetics trade was made in Q1 2013.
Since then Chuck Royce bought shares twelve more times and sold shares on sixteen occasions. The investor sold all their shares in Q3 2020 and doesn't own any shares in Myriad Genetics anymore.
Avg closing price
Price range
Sold -3.16 Thousand shares
Q3 2020
Avg closing price
$12.66
Price range
$11.25
-
$14.75
Increased shares by 10.0% (+287 shares)
Q2 2020
Avg closing price
$14.20
Price range
$10.69
-
$16.49
Increased shares by 38.4% (+796 shares)
Q1 2020
Avg closing price
$21.13
Price range
$9.78
-
$29.53
Sold 98.9% shares (-191 Thousand shares)
Q4 2019
Avg closing price
$27.51
Price range
$20.93
-
$35.10
Increased shares by 8.8% (+15.7 Thousand shares)
Q3 2019
Avg closing price
$29.14
Price range
$22.08
-
$47.08
Increased shares by 24.8% (+35.3 Thousand shares)
Q2 2019
Avg closing price
$28.24
Price range
$22.67
-
$35.00
Increased shares by 1194.8% (+131 Thousand shares)
Q1 2019
Avg closing price
$30.44
Price range
$26.93
-
$34.70
Sold 83.8% shares (-56.8 Thousand shares)
Q4 2018
Avg closing price
$35.97
Price range
$27.23
-
$45.56
Increased shares by 0.3% (+225 shares)
Q3 2018
Avg closing price
$44.47
Price range
$37.57
-
$50.34
Increased shares by 0.2% (+116 shares)
Q2 2018
Avg closing price
$33.78
Price range
$27.75
-
$40.17
Increased shares by 146.2% (+40 Thousand shares)
Q1 2018